US equities |
INTC $65.27 ▼-29.11% AMZN $238.62 ▼-2.12% MU $890.25 ▼-4.71% NVDA $206.32 ▼-3.44% SNDK $1,208.44 ▼-9.14% GOOGL $280.58 ▼-1.14% AMD $512.75 ▼-9.48% AAPL $344.52 ▼-1.26%
FinancialContent

Articles published by Helius Medical Technologies, Inc.

< Previous 1 2 Next >
News headline image
Preeminent SOL Treasury Company Helius (NASDAQ:HSDT) Announces Corporate Name Change to Solana Company and Letter of Intent with Solana Foundation
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Announces FDA 510(k) Submission for PoNS® Device Label Expansion in Stroke
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius (NASDAQ:HSDT) Begins Purchases of SOL, the Native Asset of Solana Blockchain
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Medical Technologies, Inc. Compliant with Nasdaq’s Continued Listing Requirements
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Medical Technologies Announces Reverse Stock Split
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) Device
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing Criteria
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS Therapy® at CMSC Annual Meeting
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Medical Technologies Announces Reverse Stock Split
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Announces First Portable Neuromodulation Stimulator (PoNS®) System Sale to the Veterans Affairs (VA) Healthcare System
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS®) Device
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Medical Technologies, Inc. Announces Exploration of Strategic Alternatives
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Medical Technologies, Inc. to Release Second Quarter 2024 Financial Results on August 12, 2024
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Medical Technologies, Inc. Announces Third-Party Reimbursement for PoNS® from Major Insurance Carrier
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
News headline image
Helius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MS
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
< Previous 1 2 Next >